Short Interest in Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Increases By 256.9%

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) was the target of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 1,431 shares, a growth of 256.9% from the August 15th total of 401 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 396 shares, the days-to-cover ratio is presently 3.6 days.

Orion OYJ Price Performance

Shares of Orion OYJ stock opened at $46.00 on Monday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.64 and a quick ratio of 1.48. The company has a market cap of $12.98 billion, a PE ratio of 18.93 and a beta of 0.08. The firm has a fifty day moving average price of $42.86 and a two-hundred day moving average price of $40.12. Orion OYJ has a fifty-two week low of $30.89 and a fifty-two week high of $46.00.

Orion OYJ (OTCMKTS:ORINY) last posted its quarterly earnings data on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. The company had revenue of $606.38 million for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%.

Orion OYJ Company Profile

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.